• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • Devex CheckUp

    Devex CheckUp: An African pharma ‘titan’ ventures into vaccines

    In this week's edition: The African Union has set an ambitious goal for the continent's manufacturers to meet vaccine needs by 2040, but is it feasible? Plus, Africa CDC also has big ambitions for digital health, and PEPFAR turns 20 this year.

    By Jenny Lei Ravelo, Amruta Byatnal // 26 January 2023

    It’s a fact we’ve heard and written too many times: Africa is overly reliant on vaccines from abroad, importing 99% of its supply. That didn’t seem to be a global health priority — until COVID-19 came along and many African countries were left waiting for doses to arrive.

    There are now efforts to change that, with the African Union setting an ambitious goal: African manufacturers should develop, produce, and supply more than 60% of the continent’s vaccine needs by 2040 — up from less than 1% currently.

    But just how feasible is that? African manufacturers and potential investors are looking at one pharmaceutical company as a test case, namely South African company Aspen Pharmacare, dubbed by one expert as “a titan of the African pharmaceutical production landscape.”

    This article is free to read - just register or sign in

    Access news, newsletters, events and more.

    Join usSign in
    • Global Health
    • Research
    • Trade & Policy
    • Social/Inclusive Development
    • Private Sector
    • PEPFAR
    • Africa CDC
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the authors

    • Jenny Lei Ravelo

      Jenny Lei Ravelo@JennyLeiRavelo

      Jenny Lei Ravelo is a Devex Senior Reporter based in Manila. She covers global health, with a particular focus on the World Health Organization, and other development and humanitarian aid trends in Asia Pacific. Prior to Devex, she wrote for ABS-CBN, one of the largest broadcasting networks in the Philippines, and was a copy editor for various international scientific journals. She received her journalism degree from the University of Santo Tomas.
    • Amruta Byatnal

      Amruta Byatnalamrutabyatnal

      Amruta Byatnal is a Senior Editor at Devex where she edits coverage on global development, humanitarian crises and international aid. She writes Devex CheckUp, a weekly newsletter on the latest developments in global health. Previously, she worked for News Deeply in the United States, and The Hindu in India. She is a graduate of Cornell University where she studied international development. She is currently based in New Delhi.

    Search for articles

    Related Stories

    Global HealthRFK Jr. takes a lot of heat during first confirmation hearing

    RFK Jr. takes a lot of heat during first confirmation hearing

    Devex CheckUpDevex CheckUp: WHO's emergencies czar is out — here's who's in

    Devex CheckUp: WHO's emergencies czar is out — here's who's in

    Devex CheckUpDevex CheckUp: Exempted or not? Trump’s orders spark confusion

    Devex CheckUp: Exempted or not? Trump’s orders spark confusion

    Devex CheckUpDevex CheckUp: Who will pay to end the AIDS epidemic?

    Devex CheckUp: Who will pay to end the AIDS epidemic?

    Most Read

    • 1
      How to use law to strengthen public health advocacy
    • 2
      Closing the loop: Transforming waste into valuable resources
    • 3
      House cuts US global education funding 20%, spares multilateral partners
    • 4
      Lasting nutrition and food security needs new funding — and new systems
    • 5
      Opinion: The pursuit of remission — from possibility to priority
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement